Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV001819628 | SCV002070647 | uncertain significance | not specified | 2019-04-26 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001869705 | SCV002310416 | uncertain significance | Warts, hypogammaglobulinemia, infections, and myelokathexis | 2021-05-27 | criteria provided, single submitter | clinical testing | This variant is present in population databases (rs147467366, ExAC 0.001%). This sequence change replaces serine with cysteine at codon 46 of the CXCR4 protein (p.Ser46Cys). The serine residue is moderately conserved and there is a moderate physicochemical difference between serine and cysteine. This variant has not been reported in the literature in individuals with CXCR4-related conditions. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. |
Mayo Clinic Laboratories, |
RCV002261389 | SCV002541858 | uncertain significance | not provided | 2021-12-28 | criteria provided, single submitter | clinical testing |